A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1997
12/30/1997	US5703118 Use of benzopyran derivatives for the treatment of pathologies associated with the NA+ -independent CI-/HCO3 -exchanger
12/30/1997	US5703109 Cyanophenyl-1,2,4-triazole derivative
12/30/1997	US5703106 Treating various cardiovascular, urogenital, brain disorders
12/30/1997	US5703096 Oxime derivatives, their preparation and their therapeutic use
12/30/1997	US5703095 Prevention ferritin from releasing oxygen
12/30/1997	US5703074 Osteoporosis
12/30/1997	US5703052 Sterodial glycosides for treating hypercholesterolemia
12/30/1997	US5702752 Production of isoflavone enriched fractions from soy protein extracts
12/30/1997	US5702696 For treatment of iron overload disorders
12/30/1997	CA2142707C Benzo-fused lactams promote release of growth hormone
12/30/1997	CA2085231C Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained
12/29/1997	EP0814080A1 Squalene synthetase inhibitors
12/29/1997	EP0814077A1 Benzoylguanidines, process for their preparation and medicaments containing them
12/29/1997	EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines
12/29/1997	EP0813543A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/29/1997	EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders
12/29/1997	EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity
12/29/1997	EP0813414A1 Combination of bisphosphonates and growth hormone secretagogues
12/29/1997	EP0764026A4 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
12/29/1997	EP0648120B1 Use of phosphonates for the treatment of osteoporosis
12/29/1997	EP0647145B1 Storing stable bicarbonate solutions
12/29/1997	EP0569564B1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
12/24/1997	WO1997048713A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b
12/24/1997	WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof
12/24/1997	WO1997048419A1 Gene therapy for obesity
12/24/1997	WO1997042941A3 Buccal delivery system
12/24/1997	WO1997040006A3 Phosphate mimics
12/24/1997	WO1997036497A3 Cocoa extract compounds and methods for making and using the same
12/24/1997	CN1168678A Method of treating diabetes mellitus using KGF
12/24/1997	CN1168273A 蜂蛹钙制剂 Pupae calcium preparations
12/24/1997	CA2258504A1 Gene therapy for obesity
12/24/1997	CA2257361A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b
12/23/1997	US5700795 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of type II diabetes
12/23/1997	US5700791 Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof
12/23/1997	US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines
12/20/1997	CA2208174A1 Squalene synthetase inhibitors
12/18/1997	WO1997047744A2 T-cell selective interleukin-4 agonists
12/18/1997	WO1997047612A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same
12/18/1997	WO1997047584A1 Polyol succinates and their pharmaceutical formulation
12/18/1997	WO1997047308A1 Eutrophic drug compositions based on transferrin glycans
12/18/1997	WO1997047298A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	CA2257693A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	CA2257275A1 New substituded 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
12/18/1997	CA2256459A1 T-cell selective interleukin-4 agonists
12/18/1997	CA2207886A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
12/17/1997	EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists
12/17/1997	EP0812209A1 Cochleate phospholipids in drug delivery
12/17/1997	EP0812197A2 Use of moxonidine for the treatment of atherosclerosis
12/17/1997	EP0202276B2 Composition for the treatment of psoriasis
12/17/1997	CN1168103A Dermatological use of vitamin D derivs.
12/17/1997	CN1168099A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for treatment or prophylaxis of obesity
12/17/1997	CN1168098A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for treatment or prophylaxis of hyperlipopropteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia
12/17/1997	CN1167759A Substd. 2-naphthoyl guanidines, their preparing method, use and drug contg. them
12/17/1997	CN1167758A Substd. 1-naphthoyl guanidines, their preparing method, use and drug contg. them
12/17/1997	CN1167752A Novel retinoids derivs.
12/17/1997	CN1167617A Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
12/16/1997	US5698691 Condensed cyclic compounds and their use
12/16/1997	US5698669 Tri-arginine insulins
12/16/1997	US5698594 Treatment and prevention of risk factors for cardiovascular diseases
12/16/1997	US5698578 Protein kinase C inhibitors
12/16/1997	US5698551 Treatment of diabetic neuropathy, migraines, neurogenic inflammation, rheumatic arthritis and insulin resistance
12/16/1997	US5698548 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
12/16/1997	US5698542 Compound comprising tetracycline type antibiotic linked to steroid type hormone
12/16/1997	US5698541 2,4-diphosphonoglutaric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
12/16/1997	US5698519 Polypeptide specifically inhibiting cathepsin L
12/16/1997	US5698190 Vinyl polymers modified with guanidino groups; effective in removing excess phosphate from the blood
12/16/1997	CA2168829C Paroxetine hydrochloride anhydrate forms a,b,c and d
12/16/1997	CA2122002C Alteration of rate and character of hair growth
12/16/1997	CA2111446C Chiral intermediates for the preparation of antidiabetics thiazoles
12/11/1997	WO1997046585A2 Fragments of leptin (ob protein)
12/11/1997	WO1997046584A1 Exendin analogues, processes for their preparation and medicaments containing them
12/11/1997	WO1997046579A1 Neuropeptide y agonists
12/11/1997	WO1997046556A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
12/11/1997	WO1997046522A1 Novel vitamin d analogues
12/11/1997	WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
12/11/1997	WO1997046234A1 Pharmaceutical compositions containing mesembrine and related compounds
12/11/1997	WO1997046233A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
12/11/1997	WO1997046230A1 Method for maintaining an existing level of body fat and/or body weight
12/11/1997	WO1997046226A2 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
12/11/1997	WO1997046118A1 Dietetic foods containing conjugated linoleic acids
12/11/1997	WO1997040017A3 Modulators of molecules with phosphotyrosine recognition units
12/11/1997	CA2257424A1 Neuropeptide y agonists
12/11/1997	CA2257299A1 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for production of a medicament for the normalization of serum lipids
12/11/1997	CA2257240A1 Fragments of leptin (ob protein)
12/11/1997	CA2257206A1 Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
12/11/1997	CA2257119A1 Exendin analogues, processes for their production and pharmaceutical preparations containing them
12/11/1997	CA2256653A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
12/11/1997	CA2254716A1 Dietetic foods containing conjugated linoleic acids
12/10/1997	EP0811610A1 Ortho-substituted benzoylguanidines process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/10/1997	EP0811380A2 Use of vanadiumcompositions for lowering blood sugar levels
12/10/1997	EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
12/10/1997	EP0810868A1 Use of piperine as a bioavailability enhancer
12/10/1997	EP0810866A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment
12/10/1997	EP0708766B1 Use of coumarins as pla 2-inhibitors, new coumarins, process for preparing the same and medicaments
12/10/1997	EP0417209B1 Compositions and methods for administering therapeutically active compounds
12/10/1997	CN1167439A Medicinal composition for diabetes
12/10/1997	CN1167111A Thiazolidinedione derivatives, method for preparing derivatives and pharmaceutical compositions containing same
12/10/1997	CN1036651C Method for prepn. of carbostyril derivatives
12/09/1997	US5696162 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compound having retinoid like biological activity
12/09/1997	US5696141 Isoxazoline compounds as 5-lipoxygenase inhibitors

1 ... 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 ... 1298